USING SOCIAL MEDIA POSTS TO UNDERSTAND THE HEALTH INFORMATION NEEDS FOR OLDER ADULTS WITH DEMENTIA
Ebenezer Larnyo, Karim Benyassine, Natasha Preece
us (code pays fourni par la source)
0 citations
Innovation in Aging
Natasha Preece
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
29Publications signalées
1518Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Melanoma and MAPK PathwaysSynthesis and biological activityComputational Drug Discovery MethodsRenal cell carcinoma treatmentCancer Mechanisms and Therapy
Les publications récentes
Effect of social capital, social support and social network formation on the quality of life of American adults during COVID-19
Ebenezer Larnyo, Sharon Tettegah, Brianna M. Griffin, Jonathan Aseye Nutakor et autres
us, cn (code pays fourni par la source)
33 citations
Scientific Reports
Data from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres
gb, be (code pays fourni par la source)
0 citations
Supplementary Figures 1-5 and Supplementary Table 1 from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres
0 citations
Supplementary Figures 1-5 and Supplementary Table 1 from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres
0 citations
Data from Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo, Mark R. Nathan et autres
0 citations
Data from A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF
Steven R. Whittaker, Delphine Ménard, Lesley A. Ogilvie, Douglas Hedley et autres
0 citations
Supplementary Table 1 from A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF
Steven R. Whittaker, Delphine Ménard, Lesley A. Ogilvie, Douglas Hedley et autres
0 citations
Supplementary Table 2 from A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF
Steven R. Whittaker, Delphine Ménard, Lesley A. Ogilvie, Douglas Hedley et autres
0 citations
Supplementary Figure 1 from A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF
Steven R. Whittaker, Delphine Ménard, Lesley A. Ogilvie, Douglas Hedley et autres
0 citations
Supplementary Figure 1 from A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF
Steven R. Whittaker, Delphine Ménard, Lesley A. Ogilvie, Douglas Hedley et autres
0 citations
Supplementary Table 2 from A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF
Steven R. Whittaker, Delphine Ménard, Lesley A. Ogilvie, Douglas Hedley et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.